GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SQI Diagnostics Inc (FRA:XSQ) » Definitions » Cyclically Adjusted PB Ratio

SQI Diagnostics (FRA:XSQ) Cyclically Adjusted PB Ratio : (As of May. 25, 2024)


View and export this data going back to 2010. Start your Free Trial

What is SQI Diagnostics Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


SQI Diagnostics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for SQI Diagnostics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SQI Diagnostics Cyclically Adjusted PB Ratio Chart

SQI Diagnostics Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.93 1.19 3.50 3.57 3.05

SQI Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.80 3.68 3.05 3.63 2.20

Competitive Comparison of SQI Diagnostics's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, SQI Diagnostics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SQI Diagnostics's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SQI Diagnostics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where SQI Diagnostics's Cyclically Adjusted PB Ratio falls into.



SQI Diagnostics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

SQI Diagnostics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, SQI Diagnostics's adjusted Book Value per Share data for the three months ended in Mar. 2023 was:

Adj_Book=Book Value per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.027/122.7021*122.7021
=-0.027

Current CPI (Mar. 2023) = 122.7021.

SQI Diagnostics Quarterly Data

Book Value per Share CPI Adj_Book
201306 0.095 97.182 0.120
201309 0.070 97.419 0.088
201312 0.044 96.945 0.056
201403 0.046 98.604 0.057
201406 0.068 99.473 0.084
201409 0.052 99.394 0.064
201412 0.035 98.367 0.044
201503 0.029 99.789 0.036
201506 0.009 100.500 0.011
201509 0.020 100.421 0.024
201512 0.034 99.947 0.042
201603 0.025 101.054 0.030
201606 0.011 102.002 0.013
201609 0.025 101.765 0.030
201612 0.014 101.449 0.017
201703 0.027 102.634 0.032
201706 0.016 103.029 0.019
201709 0.006 103.345 0.007
201712 0.018 103.345 0.021
201803 0.010 105.004 0.012
201806 0.001 105.557 0.001
201809 0.008 105.636 0.009
201812 0.001 105.399 0.001
201903 0.004 106.979 0.005
201906 -0.002 107.690 -0.002
201909 0.005 107.611 0.006
201912 -0.001 107.769 -0.001
202003 0.004 107.927 0.005
202006 0.008 108.401 0.009
202009 0.004 108.164 0.005
202012 0.006 108.559 0.007
202103 0.005 110.298 0.006
202106 0.007 111.720 0.008
202109 0.003 112.905 0.003
202112 0.007 113.774 0.008
202203 0.005 117.646 0.005
202206 -0.003 120.806 -0.003
202209 -0.020 120.648 -0.020
202212 -0.022 120.964 -0.022
202303 -0.027 122.702 -0.027

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SQI Diagnostics  (FRA:XSQ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


SQI Diagnostics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of SQI Diagnostics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SQI Diagnostics (FRA:XSQ) Business Description

Traded in Other Exchanges
N/A
Address
36 Meteor Drive, Toronto, ON, CAN, M9W 1A4
SQI Diagnostics Inc is the leader in the field of lung health. The company develops and manufactures respiratory health and precision medicine tests that run on SQI's automated systems. The company is developing tests to simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada, and Europe. Canada accounts for more than half of its revenues.

SQI Diagnostics (FRA:XSQ) Headlines

No Headlines